Changzhou Qianhong Biopharma CO.,LTD

Shenzhen Stock Exchange:002550.SZ

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

China

Market Cap

USD 1.81 B

Share Price

USD 1.42

Avg Daily Volume

114,717,936

Change (1 day)

-4.80%

Change (1 year)

79.80%

Change (YTD)

67.00%

Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2024: 26.03%

Changzhou Qianhong Biopharma CO.,LTD EBIT Margin is 26.03% for the year ending December 31, 2024, a 124.95% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2023 was 11.57%, a -28.80% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2022 was 16.25%, a 40.32% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2021 was 11.58%, a -229.62% change year over year.
Changzhou Qianhong Biopharma CO.,LTD EBIT Margin for the year ending December 31, 2020 was -8.93%, a -150.11% change year over year.